Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest

Resuscitation

Volumn 50, Issue 1, 2001, Pages 71-76

  Lederer, Wolfgang ^a   Lichtenberger, Christa ^b   Pechlaner, Christoph ^a   Kroesen, Gunnar ^a   Baubin, Michael ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Enns District Hospital   (Austria)

Author keywords

Adult; Cardiac arrest; Cardiopulmonary resuscitation (CPR); Circulation; Emergency medical services; Thrombolysis

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

AGED; BLOOD CIRCULATION; CARDIOPULMONARY RESUSCITATION; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HEART ARREST; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLASMINOGEN ACTIVATORS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034907583     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(01)00317-3     Document Type: Conference Paper

References (24)

1. Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC)
2. Cardiac arrest and resuscitation: A tale of 29 cities
3. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients
4. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism
5. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
6. Rescue thrombolysis in patients with prehospital cardiopulmonary arrest and ineffective conventional resuscitation efforts
7. Safety of thrombolysis in association with cardiopulmonary resuscitation
8. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest
9. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis
10. Myocardial perfusion during cardiopulmonary resuscitation (CPR): Effects of 10, 25, and 50% coronary stenoses
11. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: An experimental study in the cat
12. Research work on blood clotting system during cardiorespiratory resuscitation
13. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Resulsts of the rt-PA-APSAC patency study (TAPS)
14. The 1998 European Resuscitation Council Guidelines for Adult Advanced Life Support
15. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: The Utstein style. European Resuscitation Council, American Heart Association, Heart and Stroke foundation of Canada and Australian resuscitation Council
16. Who gets bystander cardiopulmonary resuscitation in a witnessed arrest?
17. Thrombolysis during cardiopulmonary resuscitation
18. Cause of death in unsuccessful prehospital resuscitation
19. Unexpected findings and complications at autopsy after cardiopulmonary resuscitation (CPR)
20. Predicting survival from out-of-hospital cardiac arrest: A multivariate analysis
21. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction
22. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
23. Urokinase versus tissue plasminogen activator in pulmonary embolism
24. Cost-benefit analysis a prerequisite of a rational pharmacotherapy in cardiovascular diseases. Timely thrombolysis in the acute myocardial infarction